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Introduction
Telemedicine is the use of telecommunications technology to provide health care from a distance. Its implementation in medical care has become increasingly popular in recent years, especially in patients with chronic diseases [1] [2] [3] [4] . In chronic heart disease, telemedicine is associated with a reduction of hospitalization and readmissions, lower mortality, and improved clinical outcome and cost-effectiveness of care [5] . The use of telemedicine in health care meets the tendency toward personalized medicine and the need to control rising health-care costs, including an individual approach and migration of care toward home with the use of remote monitoring, education of patients, and virtual visits to medical professionals [2] .
Telemedicine can be divided into educational or supportive websites, telecoaching, telemonitoring, telerehabilitation, and teleconsultation [6] . Various aspects, such as telemonitoring, telecoaching, and teleconsultation, can be potentially important tools in the treatment of patients with peripheral arterial disease (PAD). Patients with PAD are usually old, frail and multimorbid, and could benefit from monitoring of health parameters and vascular risk factors. Moreover, these patients frequently have mobility issues and could thus particularly benefit from techniques that reduce the need for hospital visits. Possible targets for monitoring include regulation of hypertension, weight, renal function, diabetes management, hyperlipidemia control, smoking behavior, and wound status. In addition, telemedicine could be used to improve secondary prevention and lifestyle coaching.
In this systematic review, we summarize the currently available literature on the application of telemedicine in patients with PAD.
Methods
terms (Medical Subject Headings in PubMed, Subject Headings in CINAHL and Emtree in Embase) and also free-text terms. The full search strategy is added as Supplementary. Additional studies were identified by reviewing the reference lists of the studies found in the search.
Selection criteria
Articles were eligible according to the PICO framework if they included patients with PAD of the aorta-pedal trajectory (P), a telemedicine intervention based on patient monitoring (I), either a control group receiving standard of care or no control group (C), and patient outcome measures as described in section 2.4 (O). Telemonitoring was defined as in-hospital or transmural monitoring of patients through wireless measurement of vital parameters or activity or through electronic questionnaires regarding health, based on which coaching or feedback might be provided. Telemonitoring intervention is defined if telemonitoring is used to intervene if necessary. Exclusion criteria were: no PAD patients; no telemonitoring intervention; no outcome measures as described in section 2.4; patients younger than 18 years old; or no full-text available. Access to full-text articles was gained through our medical library or in case of unavailability through direct contact with the author. If no full text was available after these attempts, articles were excluded. There were no restrictions on the setting of telemedicine (in-hospital, long-term, perioperative, and at home), language or sample size. Because the subject of telemedicine is yet a new and growing field of expertise, we decided not to limit the search to specific study types, with the exception of case reports, reviews, commentaries, letters to the editor, or conference abstracts.
Data collection and quality assessment
After duplicates were removed, two authors (MH, SK) independently screened the titles and abstracts of the identified studies for relevance. The full text of the remaining relevant studies were read by two authors (MH, SK), and a final selection of relevant studies was made. In case of discrepancies between the two reviewers, a third author was consulted (KM). The methodological quality of the randomized and nonrandomized studies was assessed using the checklist described by Downs and Black [8] . Two reviewers (MH, RB) independently evaluated the study quality, and discrepancies were discussed until consensus was reached. The thresholds used to classify study quality were good (9) (10) (11) (12) (13) (14) (15) (16) , moderate (17) (18) (19) (20) (21) (22) (23) , and poor (below 14) [6].
Outcome measures and data analysis
The primary outcome measures were disease-specific healthrelated outcomes (wound) complications, and quality of life (QoL). Secondary outcomes were office visits, hospital readmissions, and hospital length of stay. Data extracted included the year of publication, study design, study period, study inclusion criteria, age of included patients, sample size, control group, interventions, telemedicine instruments, and outcome measures, as mentioned. Reported baseline and postinterventional change in outcome measures were extracted to compare the intervention group with the control group.
The heterogeneity in study design, type of telemedicine applied, and outcome measures described precluded pooling of data or performing a meta-analysis. Therefore, we present a narrative summary of the included studies consisting of study characteristics and outcomes. Subgroups of different intervention types are presented separately.
Results

Description of study selection
A systematic literature search identified 1249 records ( Figure 1 ). After the duplicates were removed, 872 records remained for the title and abstract screening. From these, 854 were excluded because they did not meet the inclusion criteria, mainly because other patient populations were described (mostly carotid or cerebral artery diseases) or a telemonitoring intervention was absent. Full-text assessment of the remaining 18 articles resulted in six articles fulfilling the inclusion criteria of this review [17, [24] [25] [26] [27] [28] . The characteristics of the included studies are summarized in Table 1 . Table 2 reports the outcomes of the included studies. The excluded full-text papers with the reason for exclusion are listed in Table 3 .
The included studies described a total of 477 patients, with a mean sample size of 80 patients (range, , and were all published in 2018 or 2019. The ages of these patients ranged from 62.5 to 70.2 years. Five randomized controlled trials (RCTs) were included [17, 24, 25, 27, 28] and one prospective cohort study [26] . Two studies were focused on telemonitoring tools to monitor surgical site infections (SSIs) [17, 26] and post-discharge complications [17] after vascular surgery. The four other RCTs included telecoaching tools in patients with PAD who underwent home-based exercise intervention [24, 27, 28] or a self-management program [25] .
Methodological quality of included studies
The study quality scores are reported in Table 1 scored low at blinding subjects and clinicians to the intervention and outcome measurement and at making clear which analysis was not planned at the outset of the study.
Post-operative telemonitoring
One feasibility study and one RCT on post-operative telemonitoring were identified. Gunter et al. [26] evaluated the feasibility and use of a WoundCheck app in a prospective analysis of 47 consecutive patients, of which 40 completed a 14-day post-operative follow-up protocol. All patients underwent a vascular surgical procedure with an incision of at least 3 cm and were trained to use the WoundCheck app during admission. Patients used the app to send a daily photo of the wound and to answer questions about their recovery. During follow-up, eight SSIs were recorded, seven of which were detected using the WoundCheck app, with no false positives. Three patients were readmitted: one after falling on the amputation stump, one for respiratory failure, and one because of an unresolved SSI after antibiotic therapy. The authors concluded that the protocol including the WoundCheck app can be completed by patients and health-care providers. In addition, the app led to the detection and treatment of SSIs before routine follow-up visits occurred in standard care.
Moussa et al. [17] evaluated clinical outcomes, use, feasibility, patient satisfaction, and QoL after vascular procedures with infrainguinal incisions in patients receiving TeleHealth Electronic Monitoring (THEM) or standard care. THEM comprises daily measurements of blood pressure, heart rate, oxygen saturation, weight, and temperature, which are manually registered by the user in a tablet and monitored by a healthcare provider for abnormalities. Of 30 patients, 16 were randomly assigned to the intervention group and instructed to record the THEM parameters until the first follow-up visit. The tablet was also used for daily and weekly quiz questions and system alerts based on measurements or quiz answers. Care managers monitored values daily, contacted patients based on the system alerts, and requested pictures of the surgical site for assessment and comparison. No significant differences Differences between both groups in post-intervention scores. *Significantly different between both groups, p < 0.05.
were found between the groups in the number of readmissions within 30 days, office visits, or SSI, as reported in Table 2 . However, care managers identified more wound problems in the THEM group, but without significance (5 vs. 1, p = 0.175).
Patients in the THEM group had a significantly more pronounced increase between the pre-and post-operative QoL subscales of physical function (7.5 vs. 1.1, p = 0.002) and physical role (8.7 vs. 1.1, p = 0.001) as measured with the 8-Item Short Form Health Survey. The authors concluded that THEM was technically feasible, improved patient satisfaction, and successfully merged remotely generated information with patient management.
Telecoaching in PAD
Four RCTs were identified that investigated the use of telemedicine in patients with PAD. Davins Riu et al. [25] created a telehealth program called Control Telehealth Claudication Intermittent (CONTECI) to improve patient education, empowerment, and selfmanagement. In this RCT, they assessed the efficacy of CONTECI as a monitoring tool in PAD patients with intermittent claudication over 12 months in clinical aspects (walking distance, Fontaine classification, number of surgical interventions), patient satisfaction, and QoL. Of the 150 included patients, 75 were randomly assigned to the intervention group and 75 to the control group. The intervention group used the CONTECI program from a computer or mobile device every 3 months to answer a dynamic questionnaire based on which they were advised to continue as before or to request a visit. The control group was monitored during standard visits every 6 months. QoL improved in both groups and improved significantly in the intervention group between baseline and 12 months' follow-up (67.9 vs. 72.3, p = 0.047). However, no significant differences in QoL at 12 months were found between the two groups (p = 0.195). Control visits were reduced by 95.95% in the intervention group, and therefore, the frequency of control visits was significantly lower than in the control group (2.2 ± 0.6 vs. 0.3 ± 0.7, p = 0.000). There were fewer emergency department visits in the intervention group compared with the control group (0.017 ± 0.48 vs. 0.19 ± 0.48, p = 0.017); however, these patients visited sooner in case of a complication than patients from the control group (7.9 vs. 53.9 days, p = 0.016). No differences were found between the groups regarding the clinical variables of walking distance, claudication distance, and need for surgery. The authors concluded that the use of the CONTECI program is feasible, promotes patient expertise, and is of added value without clinical inferiority to conventional management.
Duscha et al. [28] investigated the effect of a 12-week home-based mobile health intervention on the functional capacity and physical activity patterns of sedentary patients with intermittent claudication. Before randomization and during weeks 11 and 12, all patients wore a Fitbit Charge (Fitbit, Inc., San Francisco, CA) device for activity tracking. The study randomized 20 patients between intervention and standard of care. The intervention group (n = 10) received weekly e-mails with a PAD tip and monthly feedback with exercise prescriptions based on the number of steps per day measured with the Fitbit. Patients in the intervention group showed significantly more improvement compared with the control group in differences between pre-and post-intervention claudication onset time (204.6 ± 280.6 s vs. -21.0 ± 142.7 s, p < 0.05), maximum oxygen consumption volume (20.3% ± 26.4% vs. 1.0% ± 6.9%, p < 0.05), and peak walking time (227.6 ± 286.5 s vs. 22.4 ± 107.7 s, p < 0.06). Daily step counts were not significantly different between the groups. These findings indicate that a mobile health intervention as an alternative to supervised site-based exercise therapy for PAD patients might be effective and additionally could provide a longterm solution after completing such a supervised program, especially for those not able to attend on-site supervised exercise therapy.
McDermott et al. [27] also developed a home-based monitored exercise program for PAD patients. The aim of their trial was to investigate whether a 9-month intervention, based on telephone coaching and wearable activity monitoring, could improve walking endurance and patient-reported outcomes. The intervention group comprised 97 randomly assigned patients who received individualized coaching on exercise goals and challenges. A website accessible to both patient and coach was used to enter exercise goals by a coach during telephone contact (subsequently once weekly, every 2 weeks, or every month over a 9-month period), enter the walking exercise minutes by the participant; and upload data from a Fitbit Zip (Fitbit, Inc., San Francisco, CA) device via Bluetooth. The control group (n = 101) received standard of care and were contacted by phone every 3 months to obtain information on physical activity and walking exercise frequency. The increase in the number of episodes of walking exercise per week was significantly greater in the intervention group than in the control group at 3 months (2.0 ± 3.7 vs. 0.7 ± 2.5, p = 0.005) and 6 months of follow-up (2.8 ± 7.3 vs. 0.9 ± 3.3, p = 0.045) but not at 9 months of follow-up (1.9 ± 5.0 vs. 0.8 ± 2.9, p = 0.09). No significant differences were found between both groups at 9 months of follow-up in the 6-min walking distance or physical functioning score on the 34-Item Short Form Health Survey. Remarkably, the control group reported a significantly greater decrease in the PROMIS-measured pain interference score for daily activities at the 9-month follow-up compared with the intervention group (−2.8 [−4.6 to −1.0] vs. 0.7 [−1.1 to 2.6], p = 0.002). The authors concluded that their home-based exercise intervention with telephone counseling and wearable activity monitoring without periodic onsite visits did not improve walking performance in patients with PAD, partly because the counseling was too infrequent.
Normahani et al. [24] conducted a pilot RCT to investigate the effect of a feedback-enabled wearable activity monitor on walking distances and QoL in patients with intermittent claudication. The study randomized 37 patients to an intervention group (n = 20) or a control group (n = 17). During 12 months, patients in the intervention group wore a Nike+ FuelBand (Nike, Inc., Beaverton, OR) around their wrist that recorded their activity and gave real-time feedback about the progression toward daily goals, so-called 'fuel points', a measure for overall movement and activity. Daily goals were adjusted at each follow-up visit at 3, 6, and 12 months based on the percentage of days that the fuel points targets were achieved. Maximum walking distances (MWD), claudication distance (CD), and scores on the Vascular Quality of Life (VascuQoL) questionnaire (scale 1-7) were collected before randomization and during each follow-up visit. Patients in the intervention groups showed significant improvements between baseline and 3-, 6-, and 12-month MWD, CD, and VascuQoL, whereas patients in the control group did not. At 3 months, however, the magnitude of change did not differ between the intervention and control group in MWD (15.5 vs. 20 m, p = 0.78) and CD (11.5 vs. 8 m, p = 0.32), but differed significantly in VascuQoL (0.78 vs 0.04, p = 0.004). At the 6-and 12-month follow-up, the magnitude of change compared with baseline was significantly higher in the intervention group than in the control group. The authors concluded that wearable activity monitors promote physical activity and might be beneficial in improving physical function and QoL in PAD patients.
Discussion
Rapid development of new technologies offers many advantages of telemedicine in patients with PAD. Telemedicine has the potential to improve clinical outcome, QoL, and cost-effectiveness of health-care interventions; however, the literature on its application is scarce. This systematic review identified six studies focused mainly on telemonitoring and telecoaching. The studies indicate that telemedicine interventions can aid in the early detection of postoperative complications, improve functional capacity, reduce claudication onset time, and improve patients' expertise and QoL. These findings, however, are based on limited numbers of patients, and the studies show conflicting results.
The aim of this review was to give an overview of the current use of telemedicine for monitoring patients with peripheral arterial disease. Since interventions for PAD patients are either supervised exercise therapy or revascularization (surgery), telemedicine applications for these patients include either monitoring of claudication exercise programs to increase walking distance or postoperative wound care and wound-related complications. The main differences between studies using one of these types of telemonitoring are the type of devices used (i.e. activity monitoring vs. application to upload wound pictures) and outcome parameters (i.e. walking performance measures vs. wound complication).
Treadmill exercises are recommended as the first line of therapy for patients with intermittent claudication because they have been shown to improve functional outcome [18] . Supervised exercise programs are preferred because unsupervised programs lack compliance [19] . Participation is still limited, however, because a supervised program requires multiple visits to an exercise center. The study of Gardner et al. showed that a step-monitored home exercise program could improve the 6-min walk distance even more than supervised exercises in these patients [20] . Calf muscle oxygen saturation, vascular function, and inflammation were also shown to improve [20] .
These results were, however, not confirmed by McDermott et al. [27] , who suggested that this might be due to [1] remote coaching being less potent than in-person visits [2] ; a mismatch between wearable activity monitoring and exercise recommendations, because the first led to an increase in overall activity level rather than to an increase in walking exercise; and [3] too infrequent counseling. This covers important factors that might withhold the implementation of telemedicine interventions in this patient population.
Traditionally, most vascular patients are regularly monitored 6 weeks post-intervention at the out-patient clinic. This holds the risk that SSIs will be missed or diagnosed late because most infections will occur <6 weeks after the intervention. Telemedicine interventions can fill this unmet need because physicians can monitor their patients at any time. Moreover, telemedicine can reduce unnecessary visits, overcome the problem of transportation issues, and enhance selfawareness, -diagnosis, and -management in vascular patients [17, 25, 26, 28] . What the optimal frequency is for monitoring of these patients is still questionable, however. Only one study described the monitoring of vital parameters in patients after vascular surgery. Mousa et al. [17] described the number of alerts based on these data (a total of 134); however, they did not mention the association between the alerts and caregiver contact or actual complications.
The most important methodological study limitations of the included papers are a limited number of studied patients or biases in patient inclusion and assignment to groups. Davins Riu et al. [25] concluded that their study was biased by selection of patients in which a telehealth program was most likely to benefit (patients with intermittent claudication symptoms, Fontaine stage II). Duscha et al. [28] studied a small sample size (10 patients in the intervention arm versus 9 patients in the standard of care arm) without preconceived power calculations. The control group might have introduced biases, because of the tendency to be older and weigh more, and because the treatment assignment was not blinded. Gunter et al. [26] performed their study on a small sample size of 40 patients from a relatively homogenous population who were familiar with the technology. McDermott et al. [27] stated that their results might not be extrapolated to patients not interested in increasing exercise activity level, that the exercise intervention was not potent enough due to the absence of direct feedback on uploaded data, and that they missed substantial data for objective measurement of physical activity. The study of Mousa et al. [17] was underpowered, since only 30 of the 80 screened patients were enrolled. In the study of Normahani et al. [24] , approximately half of the eligible patients declined to participate which resulted in a study population of only 37 patients. Besides, both the intervention and control group had access to a supervised exercise program (SEP), which makes it difficult to separate the effects of wearable activity monitoring from that of the SEP. However, only 15% (3 patients) of the patients from the intervention group and 29% (5 patients) from the control were enrolled in SEP.
Implementation of telemedicine interventions in patients PAD requires careful consideration. First, the balance between unsupervised periods and frequency of contact is delicate. The optimal frequency of real-life contact between patient and caregiver/coach has not yet been determined and probably cannot be completely replaced by teleconsultation.
Second, technology apprehension could play an important role in the adherence of patients to the telemedicine intervention. PAD patients are relatively old, and Cornelis et al. reported that only 26% of the PAD patients who owned a mobile phone (92 of 99) used apps [21] . Gunter et al. [26] had to exclude 32.5% of the patients in their study if they would not have provided smartphone devices for patients who did not own a suitable one. In the RCT of Mousa et al. [17] , 9 of 80 patients screened for inclusion refused because of apprehension toward technology. Provision of a smartphone increases the applicability to the complete patient population; however, relying on patients' own devices provides the advantage of patients' familiarity with technology and reduces the need for extra training [25] . Another bias due to technology apprehension in telemedicine studies is that patients who are successfully recruited are more inclined to use technology, lowering the generalizability of these studies [24] .
Third, compliance might also bias control groups. A pitfall of non-randomized studies is that less committed patients might prefer home-based exercise to medical center visits. Patients in the control groups might have decided to increase exercise themselves. Attention-control intervention designs might be able to overcome this bias [27] .
This systematic review has limitations. The heterogeneity of the reported studies in types of intervention, outcome measures, and follow-up duration conceptually eliminated quantification of outcome heterogeneity and precluded pooling of data to perform a meta-analysis. This precludes a definitive answer to the question whether telemedicine interventions are worth the effort.
Another limitation is that only health outcome measures were included, whereas current literature regarding telemedicine in vascular patients also emphasizes the importance of feasibility (acceptability, satisfaction, etc.) for patients and caregivers. Although not incorporated in the current review, feasibility is an important factor in the implementation of telemonitoring interventions. For example, a strength of the study of McDermott et al. [27] is that they designed their exercise intervention based on patient feedback during earlier held focus groups and pilot studies in PAD patients. Noteworthy is that multiple studies report high levels of satisfaction and feelings of reassurance owing to the telemedicine intervention [17, 26] .
Cost-effectiveness is another relevant factor that requires more attention be given to the question of whether telemonitoring is worth the effort. In (most) studies, cost-effectiveness is mentioned as a possible advantage of telemonitoring [17, [24] [25] [26] ; however, data regarding cost-effectiveness are rarely provided, and mainly based on assumptions. Assessment of costeffectiveness in healthcare should include both costs and effects within the healthcare system (such as costs of hospital stay) as well as costs outside this system (such as sick leave and travel costs) [22] . In a cost-effectiveness evaluation of a nurse-led internet-based vascular risk management program, Greving et al. [23] took into account medical costs, including medication and staff labor costs, and non-medical costs, including transportation costs and costs from paid and unpaid productivity losses. Depending on the type of telemedicine, costs of devices need to be added to such a list.
Three papers were excluded because outcome measures were the usability of a smartphone application. Shalan et al. [9] designed the YORwalK app to promote exercise in PAD patients. So far, they have tested the usability only in healthcare professionals. Garcia et al. [10] described the use of an Android application based on geolocation to control homebased exercise in five PAD patients. Gunter et al. [11] assessed the usability of the WoundCheck app, which they used for a feasibility study that was included in the current review [26] . One excluded paper described how wound progress in leg ulcer care could be followed through photographs based on two case reports [12] . Most excluded papers did not cover telemedicine interventions or did not include patients with PAD, but, for example, patient with chronic cardiovascular diseases [13, 14] . This emphasizes the limited availability of reports about the use of telemedicine in PAD patients.
Expert opinion
Telemedicine can potentially benefit patients with PAD. There are, however, some practical issues that need to be overcome before this can successfully be implemented in daily clinical practice. Patients feel satisfied and in control at the beginning of a telemedicine intervention, but at a certain point, the intervention becomes routine and motivation decreases [25] . Game-based interventions could possibly have a positive influence on exercise attitudes in vascular patients [15] . Patient input in the development of personalized telemedicine from focus groups and pilot studies might also benefit patient engagement towards such programs. Furthermore, Gunter et al. [26] mentioned concerns about program sustainability because of extra workload for nurses due to the in-hospital explanation of the intervention and processing of app information during their normal work activities. Sustainability depends on integration within the health-care system [26] and incorporation into a daily routine [24] . The latter is highly dependent on the type of devices used. For example, the ease of use of telemedicine tools (tablets, smartphone, applications, measurement instruments), the presence of feedback [24] , and level of control will probably influence patients' adherence toward telemedicine programs.
The increasing technological potential of wearable devices as a result of the development of smaller sensors and accompanied algorithms enables the measurement of more (important) clinical parameters and, therefore, the monitoring of patients anywhere. One well-known wearable sensor is the Fitbit, which was used for activity measurements in two of our included studies [27, 28] . The Fitbit is shown to be useful in other fields of medicine as well. Higher Fitbit step counts during inpatient recovery can predict lower readmission rates after metastatic peritoneal cancer surgery [16] . The Nike + FuelBand was used in one study [24] and has shown to be effective because of its ability to visualize the progress toward daily activity goals. Currently, wearable sensors are developed to monitor a range of vital parameters of patients remotely for earlier detection of post-operative deterioration [29] [30] [31] [32] . Recently, Joshi et al. [29] presented an overview of these sensors. So far, main challenges of technology for telemonitoring are [1] : improvement of the diagnostic accuracy of these sensors and algorithms as well as the improvement of battery use and capacity [2] ; the measurement of (continuous) wireless, non-invasive blood pressure [3] ; adequate alarm criteria; and [4] privacy and storage of data. Electronic applications enable remote consultation between patients and health-care professionals [33] and can be used to: monitor patients wellbeing through wound monitoring or experience sampling (measuring experiences of daily life, such as pain and fear); inform patients about their treatment; and provide feedback and coaching.
Furthermore, telemonitoring could already be of additional value in the pre-operative phase by providing information for pre-operative screening, decision-making, and optimizing patients before surgery. The latter is known as prehabilitation, which is currently of increasing interest and is based on the 'better in, better out' principle [34] . In PAD patients, telemedicine could assist in prehabilitation by activity monitoring and coaching, for example, in patients who receive supervised exercise therapy from a physical therapist. Furthermore, mobile applications that consist of information and questionnaires can play an important role in (pre-operative) secondary risk prevention by lifestyle management coaching in this fragile population.
During the complete care trajectory of PAD patients (hospitalized or not), implementation of continuous monitoring with wearable devices could not only be used for earlier detection of deterioration but might also reduce the workload for nurses and contribute to patients' comfort and satisfaction.
However, what the optimal frequency is for monitoring and in which phase of care is unclear: continuously, hourly, daily, weekly? A pilot study in which patients are monitored in the complete peri-operative trajectory to answer these questions would be beneficial. Subsequently, the effects of implementation of telemedicine interventions in PAD patients should be further explored in larger randomized controlled trials.
It is remarkable that such an important outcome as costeffectiveness of telemonitoring (in PAD or other patient groups) is still an underexplored area. The following factors are to be considered in future cost-effectiveness assessments. First, the economic evaluation of telemonitoring interventions requires proper implementation in healthcare. Second, the definition of a cost or effect in the evaluation of telemedicine interventions compared to usual care relies on the policy level of interest [22] , whether it comprises costeffectiveness at the level of government, hospital or patient. Third, although economic evaluation of telemedicine interventions will influence its availability in the future healthcare, the success of such implementations probably also depends on hardly measurable subjective perceptions of both caregivers and patients, such as workload and feeling of security, respectively.
Standardization in reporting on outcomes of the use of telemedicine is important and further development of telemedicine guidelines is necessary. One of the important initiatives is from the American Telemedicine Association which made progress to prioritize such guidelines and development of telemedicine standards [35] . Physicians all over the world implementing telemedicine and studying the effects of telemedicine in healthcare should be encouraged to work according to these standards. Moreover, finetuning of global telemedicine guidelines and standardization in reporting on outcomes should be on the agenda in the world-leading telemedicine conferences.
In conclusion, the use of telemedicine in PAD patients is still an under-explored area. Owing to its high potential to improve physical ability, lifestyle coaching, and detection of deterioration in these patients, future research should focus on the proper implementation of telemedicine in PAD patients, including clinical, feasibility, nurses' workload, and cost-efficiency outcome measures. Over the next years, accompanied by technological improvements, telemedicine will be integrated into many fields of health care, reinforcing the tendency toward personalized medicine, facilitating the migration of care toward home, and inhibiting rising health-care costs.
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